Europe Breast Implants Market

Europe Breast Implants Market Size (2023 to 2028)

The breast implants market in Europe is estimated to be growing at a CAGR of 4.39% from 2023 to 2028 and be worth USD 0.72 billion by 2028 from USD 0.58 billion in 2023.

Breast implants contain inert substances placed in/under the breast muscle. Breast implants are used for breast implantation and breast reconstruction.

The growing number of breast cancer cases in Europe is one of the major factors propelling the European breast implant market. According to the WHO, breast cancer is the most frequent cancer among women, accounting for more than 25% of all cancer patients in the European region. In addition, many women are also drawn to breast implantation treatments because they want to have more shapely breasts. As a result of the growing desire to augment breasts, the demand for breast implants in Europe is expected to rise in the coming years. Over the forecast period, rising awareness of breast implant treatments is anticipated to offer growth opportunities. Furthermore, the adoption rate of breast implants is increasing as the growing public image of cosmetic surgery improves. Furthermore, advantages such as improved sexual and psychological well-being, improved quality of lifestyle, and increased pleasure with the appearance of the breasts should promote significant growth in the European breast implant market in the future.

Furthermore, as women’s desire for a more appealing appearance grows, more women are opting for breast augmentation treatments to change the size and form of their breasts, propelling the market growth. Furthermore, modifications in breast implant technology, such as changes in material, design, and fill volumes, should help to increase adoption by reducing rippling and wrinkling. In addition, the increasing demand for qualified plastic surgeons to perform these treatments and provide valuable consultation to patients propel the Europe breast implant market forward.

However, scarring, the rippling of breast implants, and other disadvantages of breast implants are projected to have a negative impact on European market growth in the coming years.

This research report on the Europe breast implants market has been segmented and sub-segmented into the following categories:

By Product:

• Silicone Breast Implants
• Saline Breast Implants

By Shape:

• Round
• Anatomical

By Application:

• Reconstructive Surgery
• Cosmetic Surgery

By End-Use:

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers

By Country:

• United Kingdom
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands and
• Rest of Europe

The Europe breast implants market had the second-largest share in the global market in 2022. The market is anticipated to account for a substantial share during the forecast period, and the growth of the European market is attributed to the increasing medical tourism in European countries, increased demand for aesthetic operations such as breast reconstruction, and an increase in the number of surgeons. Also, the rising importance and focus on aesthetic value and appearance will drive up demand for cosmetic operations. In Europe, breast augmentation is the most popular cosmetic operation. However, on the other hand, women are the most concerned about their safety when getting breast implants. As a result, organizations have taken several steps to increase the safety of breast implants. 

Furthermore, many European countries, such as Switzerland and Poland, provide lower-cost breast implants. Therefore, the aforementioned factors are expected to drive the European breast implant market in the future.

Germany held the largest share of the European breast implant market in 2021. The German Federal Cabinet declared in 2019 that a digital implant registry would be established to protect German patients. Germany requires that they be registered online to improve the quality and safety of medical implants.

In addition, after much effort by the Silicon Support UK organization and the European Parliament, an attempt is being made to push European and national authorities to impose stricter standards on cosmetic surgery procedures. Similarly, the British Association of Aesthetic Plastic Surgeons and the Healing Foundation have joined forces to support breast implant research. As a result, such initiatives to ensure the safety of breast implants are projected to support Europe's breast implant market expansion over the forecast period. 

KEY MARKET PLAYERS:

AbbVie Inc. (Allergan plc), Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Johnson & Johnson (Mentor Worldwide LLC), Polytech Health & Aesthetics GmbH, Silimed, Sientra Inc., and Celaplas are some of the noteworthy companies in the Europe breast implants market.